Terms: = Skin cancer AND RAF1, Raf-1, 5894, P04049, ENSG00000132155, c-Raf, CRAF AND Prognosis
9 results:
1. Combined PDE4+MEK inhibition shows antiproliferative effects in NRASQ61 mutated melanoma preclinical models.
Louveau B; Reger De Moura C; Jouenne F; Sadoux A; Allayous C; Da Meda L; Bernard-Cacciarella M; Baroudjian B; Lebbé C; Mourah S; Dumaz N
Melanoma Res; 2024 Apr; 34(2):186-192. PubMed ID: 38141200
[TBL] [Abstract] [Full Text] [Related]
2. Protein kinase C-α is upregulated by IMP1 in melanoma and is linked to poor survival.
Mahapatra L; Andruska N; Mao C; Gruber SB; Johnson TM; Fullen DR; Raskin L; Shapiro DJ
Melanoma Res; 2019 Oct; 29(5):539-543. PubMed ID: 30543563
[TBL] [Abstract] [Full Text] [Related]
3. Metastatic melanomas of unknown primary show better prognosis than those of known primary: a systematic review and meta-analysis of observational studies.
Bae JM; Choi YY; Kim DS; Lee JH; Jang HS; Lee JH; Kim H; Oh BH; Roh MR; Nam KA; Chung KY
J Am Acad Dermatol; 2015 Jan; 72(1):59-70. PubMed ID: 25440435
[TBL] [Abstract] [Full Text] [Related]
4. Expression of Raf Kinase Inhibitor Protein (RKIP) is a predictor of uveal melanoma metastasis.
Caltabiano R; Puzzo L; Barresi V; Cardile V; Loreto C; Ragusa M; Russo A; Reibaldi M; Longo A
Histol Histopathol; 2014 Oct; 29(10):1325-34. PubMed ID: 24763848
[TBL] [Abstract] [Full Text] [Related]
5. MAP kinase signaling and inhibition in melanoma.
Sullivan RJ; Flaherty K
Oncogene; 2013 May; 32(19):2373-9. PubMed ID: 22945644
[TBL] [Abstract] [Full Text] [Related]
6. Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial.
Bengala C; Bertolini F; Malavasi N; Boni C; Aitini E; Dealis C; Zironi S; Depenni R; Fontana A; Del Giovane C; Luppi G; Conte P
Br J Cancer; 2010 Jan; 102(1):68-72. PubMed ID: 19935794
[TBL] [Abstract] [Full Text] [Related]
7. Two types of human malignant melanoma cell lines revealed by expression patterns of mitochondrial and survival-apoptosis genes: implications for malignant melanoma therapy.
Su DM; Zhang Q; Wang X; He P; Zhu YJ; Zhao J; Rennert OM; Su YA
Mol Cancer Ther; 2009 May; 8(5):1292-304. PubMed ID: 19383853
[TBL] [Abstract] [Full Text] [Related]
8. The role of B-RAF in melanoma.
Gray-Schopfer VC; da Rocha Dias S; Marais R
Cancer Metastasis Rev; 2005 Jan; 24(1):165-83. PubMed ID: 15785879
[TBL] [Abstract] [Full Text] [Related]
9. Genomic alterations in blastic natural killer/extranodal natural killer-like T cell lymphoma with cutaneous involvement.
Mao X; Onadim Z; Price EA; Child F; Lillington DM; Russell-Jones R; Young BD; Whittaker S
J Invest Dermatol; 2003 Sep; 121(3):618-27. PubMed ID: 12925224
[TBL] [Abstract] [Full Text] [Related]
